Targeting cell motility in pulmonary arterial hypertension

European Respiratory Journal

Volumn 43, Issue 2, 2014, Pages 531-544

  Paulin, Roxane ^a,b   Meloche, Jolyane ^b   Courboulin, Audrey ^b   Lambert, Caroline ^b   Haromy, Alois ^a   Courchesne, Antony ^b   Bonnet, Pierre ^c   Provencher, Steeve ^b   Michelakis, Evangelos D ^a   Bonnet, Sebastien ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANIMALS; APOPTOSIS; CELL MOVEMENT; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION, PULMONARY; LUNG; MALE; MIDDLE AGED; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; YOUNG ADULT;

EID: 84893491881     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00181312     Document Type: Article

References (68)

1. McMurtry MS, Archer SL, Altieri DC, et al. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest 2005; 115: 1479-1491.
2. Voelkel NF, Cool C, Lee SD, et al. Primary pulmonary hypertension between inflammation and cancer. Chest 1998; 114: 225S-230S.
3. Paulin R, Courboulin A, Barrier M, et al. From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension. J Mol Med (Berl) 2011; 89: 1089-1101.
4. Zhang S, Fantozzi I, Tigno DD, et al. Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2003; 285: L740-L754.
5. Nohe A, Hassel S, Ehrlich M, et al. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 2002; 277: 5330-5338.
6. Yang X, Long L, Southwood M, et al. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Circ Res 2005; 96: 1053-1063.
7. Moreno-Vinasco L, Gomberg-Maitland M, Maitland ML, et al. Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension. Physiol Genomics 2008; 33: 278-291.
8. Mizuno S, Bogaard HJ, Kraskauskas D, et al. p53 gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice. Am J Physiol Lung Cell Mol Physiol 2011; 300: L753-L761.
9. Chen SJ, Wang YB, Chen O, et al. [Effect of p21 gene transfection mediated by replication deficient adenovirus on the pulmonary hypertensive rat model]. Zhonghua Er Ke Za Zhi 2008; 46: 139-142.
10. Fouty BW, Grimison B, Fagan KA, et al. p27(Kip1) is important in modulating pulmonary artery smooth muscle cell proliferation. Am J Respir Cell Mol Biol 2001; 25: 652-658.
11. Yu L, Quinn DA, Garg HG, et al. Cyclin-dependent kinase inhibitor p27Kip1, but not p21WAF1/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice. Circ Res 2005; 97: 937-945.
12. Ravi Y, Selvendiran K, Meduru S, et al. Dysregulation of PTEN in cardiopulmonary vascular remodeling induced by pulmonary hypertension. Cell Biochem Biophys 2011 [In press DOI: 10.1007/s12013-011-9332-z].
13. Paulin R, Courboulin A, Meloche J, et al. Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension. Circulation 2011; 123: 1205-1215.
14. Courboulin A, Paulin R, Giguere NJ, et al. Role for miR-204 in human pulmonary arterial hypertension. J Exp Med 2011; 208: 535-548.
15. Paulin R, Meloche J, Jacob MH, et al. Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol 2011; 301: H1798-H1809.
16. Bonnet S, Rochefort G, Sutendra G, et al. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted. Proc Natl Acad Sci USA 2007; 104: 11418-11423.
17. Mitra SK, Schlaepfer DD. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 2006; 18: 516-523.
18. Sieg DJ, Hauck CR, Ilic D, et al. FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2000; 2: 249-256.
19. Schlaepfer DD, Hou S, Lim ST, et al. Tumor necrosis factor-a stimulates focal adhesion kinase activity required for mitogen-activated kinase-associated interleukin 6 expression. J Biol Chem 2007; 282: 17450-17459.
20. Rozengurt E. Mitogenic signaling pathways induced by G protein-coupled receptors. J Cell Physiol 2007; 213: 589-602.
21. Schaller MD. Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim Biophys Acta 2001; 1540: 1-21.
22. Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 2005; 6: 56-68.
23. Lietha D, Cai X, Ceccarelli DF, et al. Structural basis for the autoinhibition of focal adhesion kinase. Cell 2007; 129: 1177-1187.
24. Schlaepfer DD, Hanks SK, Hunter T, et al. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 1994; 372: 786-791.
25. Xie B, Zhao J, Kitagawa M, et al. Focal adhesion kinase activates Stat1 in integrin-mediated cell migration and adhesion. J Biol Chem 2001; 276: 19512-19523.
26. Harte MT, Hildebrand JD, Burnham MR, et al. p130Cas, a substrate associated with v-Src and v-Crk, localizes to focal adhesions and binds to focal adhesion kinase. J Biol Chem 1996; 271: 13649-13655.
27. Bellis SL, Miller JT, Turner CE. Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase. J Biol Chem 1995; 270: 17437-17441.
28. Morrell NW, Adnot S, Archer SL, et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: S20-S31.
29. Schultze A, Fiedler W Therapeutic potential, limitations of new FAK inhibitors in the treatment of cancer. Expert Opin Investig Drugs. 2010; 19: 777-788.
30. National Institutes of Health. Principles of Laboratory Animal Care. Publication No. 85-23, revised 1996. Bethesda, MD, 1996.
31. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 1997: 35: 2-3.
32. Bonnet S, Archer SL, Allalunis-Turner J, et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 2007; 11: 37-51.
33. Calalb MB, Polte TR, Hanks SK. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol 1995; 15: 954-963.
34. Slack-Davis JK, Martin KH, Tilghman RW, et al. Cellular characterization of a novel focal adhesion kinase inhibitor. J Biol Chem 2007; 282: 14845-14852.
35. Mukhopadhyay UK, Mooney P, Jia L, et al. Doubles game: Src-Stat3 versus p53-PTEN in cellular migration and invasion. Mol Cell Biol 2010; 30: 4980-4995.
36. Gao H, Priebe W, Glod J, et al. Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium. Stem Cells 2009; 27: 857-865.
37. Geiger B, Bershadsky A. Assembly and mechanosensory function of focal contacts. Curr Opin Cell Biol 2001; 13: 584-592.
38. Schaller MD. Paxillin: a focal adhesion-associated adaptor protein. Oncogene 2001; 20: 6459-6472.
39. Taylor JM, Mack CP, Nolan K, et al. Selective expression of an endogenous inhibitor of FAK regulates proliferation and migration of vascular smooth muscle cells. Mol Cell Biol 2001; 21: 1565-1572.
40. Bond M, Sala-Newby GB, Newby AC. Focal adhesion kinase (FAK)-dependent regulation of S-phase kinaseassociated protein-2 (Skp-2) stability. A novel mechanism regulating smooth muscle cell proliferation. J Biol Chem 2004; 279: 37304-37310.
41. Umesh A, Paudel O, Cao YN, et al. Alteration of pulmonary artery integrin levels in chronic hypoxia and monocrotaline-induced pulmonary hypertension. J Vasc Res 2011; 48: 525-537.
42. Dauer DJ, Ferraro B, Song L, et al. Stat3 regulates genes common to both wound healing and cancer. Oncogene 2005; 24: 3397-3408.
43. Verma NK, Dourlat J, Davies AM, et al. STAT3-stathmin interactions control microtubule dynamics in migrating T-cells. J Biol Chem 2009; 284: 12349-12362.
44. Ng DC, Lin BH, Lim CP, et al. Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. J Cell Biol 2006; 172: 245-257.
45. Gao SP, Bromberg JF. Touched and moved by STAT3. Sci STKE 2006; 2006: pe30.
46. Silver DL, Naora H, Liu J, et al. Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility. Cancer Res 2004; 64: 3550-3558.
47. Ahn S, Park H. XIAP is essential for shear stress-enhanced Tyr-576 phosphorylation of FAK. Biochem Biophys Res Commun 2011; 399: 256-261.
48. Hu Y, Bock G, Wick G, et al. Activation of PDGF receptor a in vascular smooth muscle cells by mechanical stress. FASEB J 1998; 12: 1135-1142.
49. O'Callaghan CJ, Williams B. Mechanical strain-induced extracellular matrix production by human vascular smooth muscle cells: role of TGF-b1. Hypertension 2000; 36: 319-324.
50. Lehoux S, Esposito B, Merval R, et al. Differential regulation of vascular focal adhesion kinase by steady stretch and pulsatility. Circulation 2005; 111: 643-649.
51. Mizuno S, Bogaard HJ, Kraskauskas D, et al. p53 gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice. Am J Physiol Lung Cell Mol Physiol.
52. Lim ST, Chen XL, Lim Y, et al. Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. Mol Cell 2008; 29: 9-22.
53. Lim ST, Miller NL, Nam JO, et al. Pyk2 inhibition of p53 as an adaptive and intrinsic mechanism facilitating cell proliferation and survival. J Biol Chem 2010; 285: 1743-1753.
54. Cance WG, Golubovskaya VM. Focal adhesion kinase versus p53: apoptosis or survival? Sci Signal 2008; 1: pe22.
55. Sakao S, Taraseviciene-Stewart L, Lee JD, et al. Initial apoptosis is followed by increased proliferation of apoptosisresistant endothelial cells. FASEB J 2005; 19: 1178-1180.
56. Mathew R, Huang J, Shah M, et al. Disruption of endothelial-cell caveolin-1a/raft scaffolding during development of monocrotaline-induced pulmonary hypertension. Circulation 2004; 110: 1499-1506.
57. Mizuno S, Yasuo M, Bogaard HJ, et al. Copper deficiency induced emphysema is associated with focal adhesion kinase inactivation. PLoS One 2012; 7: e30678.
58. Voelkel NF, Quaife RA, Leinwand LA, et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute Working Group on cellular and molecular mechanisms of right heart failure. Circulation 2006; 114: 1883-1891.
59. Franchini KG, Torsoni AS, Soares PH, et al. Early activation of the multicomponent signaling complex associated with focal adhesion kinase induced by pressure overload in the rat heart. Circ Res 2000; 87: 558-565.
60. Torsoni AS, Constancio SS, Nadruz W Jr, et al. Focal adhesion kinase is activated and mediates the early hypertrophic response to stretch in cardiac myocytes. Circ Res 2003; 93: 140-147.
61. Torsoni AS, Marin TM, Velloso LA, et al. RhoA/ROCK signaling is critical to FAK activation by cyclic stretch in cardiac myocytes. Am J Physiol Heart Circ Physiol 2005; 289: H1488-H1496.
62. Fonseca PM, Inoue RY, Kobarg CB, et al. Targeting to C-terminal myosin heavy chain may explain mechanotransduction involving focal adhesion kinase in cardiac myocytes. Circ Res 2005; 96: 73-81.
63. Yi XP, Zhou J, Huber L, et al. Nuclear compartmentalization of FAK and FRNK in cardiac myocytes. Am J Physiol Heart Circ Physiol 2006; 290: H2509-H2515.
64. Senyo SE, Koshman YE, Russell B. Stimulus interval, rate and direction differentially regulate phosphorylation for mechanotransduction in neonatal cardiac myocytes. FEBS Lett 2007; 581: 4241-4247.
65. Eble DM, Strait JB, Govindarajan G, et al. Endothelin-induced cardiac myocyte hypertrophy: role for focal adhesion kinase. Am J Physiol Heart Circ Physiol 2000; 278: H1695-H1707.
66. Taylor JM, Rovin JD, Parsons JT. A role for focal adhesion kinase in phenylephrine-induced hypertrophy of rat ventricular cardiomyocytes. J Biol Chem 2000; 275: 19250-19257.
67. Umar S, Hessel M, Steendijk P, et al. Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertension. Pathol Res Pract 2007; 203: 863-872.
68. Study Of PF-00562271, including patients with pancreatic, head and neck, prostatic neoplasms. http://clinicaltrials. gov/show/NCT00666926 Last accessed: March 14, 2013 Last updated: March 14, 2013.